Thomas Akesh, Karakattu Sajin, Cagle Jeanette, Hoskere Girendra
Internal Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, USA.
Pulmonary and Critical Care Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, USA.
Cureus. 2021 Apr 21;13(4):e14605. doi: 10.7759/cureus.14605.
Introduction Pleural mesothelioma constitutes about 80% of all mesotheliomas. The peak incidence of malignant mesothelioma estimated using the cancer registries was in early 1990 to 2000 in the United States. The disease is primarily associated with asbestos exposure. The latency period between asbestos exposure and the development of malignant pleural mesothelioma (MPM) can range anywhere from 15 to 60 years. Asbestos exposure was peaked during the industrial revolution and World War II due to military and shipyard exposures. It is often difficult for the pathologist to distinguish different histological subtypes; due to the disease's rarity and the inadequate tissue sample obtained. There is no available data on the difference in epidemiology of different subtypes of MPM. Surveillance Epidemiology and End Results (SEER), cancer incidence data include population-based registries covering approximately 34.6% of the U.S. population. Here in our study, we analyze malignant pleural mesothelioma epidemiology in the United States, emphasizing different histological subtypes. Methods SEER data from 2000 to 2016 was used in our study. The primary site of cancer is selected as pleura, and malignant behavior only is selected as the filter. Data were analyzed using the SEER stat program. Overall epidemiology of MPM and epidemiology of epithelioid, fibrous, and biphasic histological subtypes were analyzed separately. We used annual percentage change (APC) to evaluate the trend in the epidemiology of MPM. Results summary A total of 11,857 cases of MPM were included in the primary cohort from the SEER 18 registry from 2000 to 2016. The total prevalence of MPM was highest in 2009 and was lowest in 2016. The APC in MPM incidence during this period is -2.0. After removing 5,989 cases with non-specified histology during the same period, the APC for each histological type is -0.7 for fibrous type, 1.8 for epithelioid type, and 2.9 for biphasic type. Out of 17 regional registries included in the study, the greatest statistically significant change in APC was seen in the Hawaiian registry -4.1. In contrast, the lowest statistically significant difference was seen in Seattle (Puget Sound) registry -1.7. The APC in the incidence of MPM among males during the study period was -2.4 while that of females was -0.9. The Iowa registry showed a statistically significant increase in APC of the epithelioid malignant mesothelioma with a statistically insignificant reduction in the overall MPM APC. Conclusion The overall incidence of MPM in the United States is declining, while the data showed an increase in the incidence of epithelioid and biphasic histological subtypes. The authors believe that these conflicting results can be attributed to improved histological diagnosis and improved biopsy techniques.
引言
胸膜间皮瘤约占所有间皮瘤的80%。根据癌症登记处的数据估计,美国恶性间皮瘤的发病高峰出现在1990年初至2000年。该疾病主要与接触石棉有关。石棉接触与恶性胸膜间皮瘤(MPM)发病之间的潜伏期可在15至60年的任何范围。由于军事和造船厂接触,石棉接触在工业革命和第二次世界大战期间达到高峰。病理学家通常很难区分不同的组织学亚型;这是由于该疾病罕见且获得的组织样本不足。目前尚无关于MPM不同亚型流行病学差异的可用数据。监测、流行病学和最终结果(SEER)癌症发病率数据包括覆盖约34.6%美国人口的基于人群的登记处。在我们的这项研究中,我们分析了美国恶性胸膜间皮瘤的流行病学,重点关注不同的组织学亚型。
方法
我们的研究使用了2000年至2016年的SEER数据。癌症的主要部位选择为胸膜,仅选择恶性行为作为筛选条件。使用SEER统计程序对数据进行分析。分别分析了MPM的总体流行病学以及上皮样、纤维样和双向组织学亚型的流行病学。我们使用年度百分比变化(APC)来评估MPM流行病学的趋势。
结果总结
2000年至2016年,SEER 18登记处的主要队列中总共纳入了11,857例MPM病例。MPM的总患病率在2009年最高,在2016年最低。在此期间MPM发病率的APC为-2.0。在去除同期5989例组织学未明确的病例后,纤维样类型的APC为-0.7,上皮样类型为1.8,双向类型为2.9。在纳入研究的17个地区登记处中,APC变化在统计学上最显著的是夏威夷登记处 -4.1。相比之下,在西雅图(普吉特海湾)登记处观察到统计学上最不显著的差异 -1.7。在研究期间,男性MPM发病率的APC为-2.4,而女性为-0.9。爱荷华登记处显示上皮样恶性间皮瘤的APC有统计学上显著的增加,而MPM总体APC有统计学上不显著的下降。
结论
美国MPM的总体发病率正在下降,而数据显示上皮样和双向组织学亚型的发病率有所增加。作者认为这些相互矛盾的结果可归因于组织学诊断的改善和活检技术的改进。